Yoshida H - Search Results

1

An upstream estrogen response element linked to exogenous p53 tumor suppressor gene expression differentiates effects of the codon 72 polymorphism.

Honda K, Kajitani K, Nobeyama H, Kira Y, Yabunaka Y, Egami M, Zhi X, Fukuda T, Yoshida H, Matsumoto Y, Ichimura T, Yaui T, Sumi T, Ishiko O. Honda K, et al. Among authors: yoshida h. Asian Pac J Cancer Prev. 2011;12(4):865-8. Asian Pac J Cancer Prev. 2011. PMID: 21790217 Free article.

2

Estradiol-17beta regulates vascular endothelial growth factor and Bcl-2 expression in HHUA cells.

Zhi X, Honda K, Sumi T, Yasui T, Nobeyama H, Yoshida H, Ishiko O. Zhi X, et al. Among authors: yoshida h. Int J Oncol. 2007 Dec;31(6):1333-8. Int J Oncol. 2007. PMID: 17982659

3

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.

Misugi F, Sumi T, Okamoto E, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O. Misugi F, et al. Among authors: yoshida h. Int J Mol Med. 2005 Oct;16(4):541-6. Int J Mol Med. 2005. PMID: 16142384

4

Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.

Noriyuki M, Sumi T, Zhi X, Misugi F, Nobeyama H, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O. Noriyuki M, et al. Among authors: yoshida h. Int J Oncol. 2007 Sep;31(3):531-6. Int J Oncol. 2007. PMID: 17671679

5

Expression of apoptosis-related proteins in advanced uterine cervical cancer after balloon-occluded arterial infusion chemotherapy as an indicator of the efficiency of this therapy.

Okamoto E, Sumi T, Misugi F, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O. Okamoto E, et al. Among authors: yoshida h. Int J Mol Med. 2005 Jan;15(1):41-7. Int J Mol Med. 2005. PMID: 15583826 Clinical Trial.

6

Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis.

Tsukioka M, Matsumoto Y, Noriyuki M, Yoshida C, Nobeyama H, Yoshida H, Yasui T, Sumi T, Honda K, Ishiko O. Tsukioka M, et al. Among authors: yoshida h, yoshida c. Oncol Rep. 2007 Aug;18(2):361-7. Oncol Rep. 2007. PMID: 17611657

7

Multiple organ failure of tumor-bearing rabbits in cancer cachexia is caused by apoptosis of normal organ cells.

Fukuda T, Sumi T, Nobeyama H, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O. Fukuda T, et al. Among authors: yoshida h. Int J Oncol. 2009 Jan;34(1):61-7. Int J Oncol. 2009. PMID: 19082478

8

Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.

Yoshida H, Sumi T, Zhi X, Yasui T, Honda K, Ishiko O. Yoshida H, et al. Anticancer Res. 2011 Apr;31(4):1271-7. Anticancer Res. 2011. PMID: 21508375

9

Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors.

Nakano Y, Sumi T, Morishita M, Fukuda T, Nobeyama H, Yoshida H, Matsumoto Y, Yasui T, Ishiko O. Nakano Y, et al. Among authors: yoshida h. Oncol Lett. 2012 Feb;3(2):281-286. doi: 10.3892/ol.2011.483. Epub 2011 Nov 15. Oncol Lett. 2012. PMID: 22740895 Free PMC article.

10

Expression of the mitotic-arrest deficiency 2 is associated with chemotherapy resistance in ovarian serous adenocarcinoma.

Nakano Y, Sumi T, Teramae M, Morishita M, Fukuda T, Terada H, Yoshida H, Matsumoto Y, Yasui T, Ishiko O. Nakano Y, et al. Among authors: yoshida h. Oncol Rep. 2012 Oct;28(4):1200-4. doi: 10.3892/or.2012.1907. Epub 2012 Jul 12. Oncol Rep. 2012. PMID: 22797604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,973 results

Search Page

Filters